Skip to main content

Published locations for Updated TRICOLORE findings support bevacizumab with S-1 and irinotecan combo as first-line regimen for mCRC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Updated TRICOLORE findings support bevacizumab with S-1 and irinotecan combo as first-line regimen for mCRC

User login

  • Reset your password
  • /content/updated-tricolore-findings-support-bevacizumab-s-1-and-irinotecan-combo-first-line-regimen
  • /hematology-oncology/article/244827/gastrointestinal-cancer/updated-tricolore-findings-support